The Europe Pet Food Nutraceuticals Market was worth USD 1.55 billion in 2021 and estimated to be growing at a CAGR of 4.08%, to reach USD 1.82 billion by 2026. Nutraceuticals are one of the fastest-growing segments of the pet industry. The usage of pet supplements and nutraceuticals is a rather recent practice in veterinary medicine.
Pet food supplements are classified as either dietary or therapeutic supplements. Dietary supplements are substances combined with the pet foods to make them nutritionally whole and well-adjusted. Therapeutic supplements (also known as nutraceuticals) are foods that are taken orally to provide a health advantage, either for deterrence or treatment of a disease.
Drivers and Restraints of Europe Pet Food Nutraceuticals Market:
The growth of the Europe Pet Food Nutraceuticals market is majorly driven by factors such as increasing urbanization, rising wages, implementation of channel specific product expansion, and varying lifestyles, leading to a drop in birth rates and an increase in the number of single person families. Pets are being considered as family members and thus the user predilection for nutrition empowered pet food is further driving the pet food nutraceutical market. However, factors such as different regulatory bodies, lack of recognition of pet food in under-developed countries, and lack of raw materials are restraining the growth of the market in this region.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2021 – 2026 |
|
Base Year |
2021 |
|
Forecast Period |
2021-2026 |
|
CAGR |
4.08% |
|
Segments Covered |
By Ingredient Type, By Function Type, By Pet Type, By Application Type |
|
Various Analyses Covered |
Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
Germany, U.K, France, Spain, and Italy. |
|
Market Leaders Profiled |
Diana group, BASF SE, Chr. Hansen A/S, Kemin Industries Inc., Nutraceutical International LLC, and Royal DSM N.V. |
Europe Pet Food Nutraceuticals Market – By Ingredient Type:
Omega 3 fatty acids
Among these, Omega 3 fatty acids lead the Pet Food Nutraceuticals market, followed by Probiotics. This demand is largely driven by the age associated diseases in pets like joints deterioration and cognitive dysfunction.
Europe Pet Food Nutraceuticals Market – By Function Type:
Europe Pet Food Nutraceuticals Market – By Pet Type:
Under this segment, dogs and cats lead the market accounting for a combined share of 75% of the market.
Europe Pet Food Nutraceuticals Market – By Application Type:
Under this segment, Immune system leads the market, followed by Food Allergies and Pain Relief.
Geographical Analysis:
The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. Amongst these, the UK leads the Pet Food Nutraceuticals market in Europe, whereas Spain is the most rapidly developing market, expanding at a CAGR of 5.21% during the forecast period. Italy is also one of the key markets for Pet Food Nutraceuticals in Europe. However, owing to swollen inflation rates, the market in Italy is projected to increase at a sluggish rate during the forecast period.
Key Players:
The major players in this market are focusing in the areas of Digestive health, weight management and beauty (Skin and Coat). The major companies dominating the Pet Food Nutraceuticals market in this region are Diana group, BASF SE, Chr. Hansen A/S, Kemin Industries Inc., Nutraceutical International LLC, and Royal DSM N.V.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Ingredient Type
5.1.1 Omega 3 fatty acids
5.1.2 Proteins and Peptides
5.1.3 Milk Bio actives
5.1.4 Probiotics
5.1.5 Dietary Fibre
5.1.6 Others
5.2 By Function type
5.2.1 Nutrition/Therapeutic
5.2.2 Supplements
5.3 By Pet Type
5.3.1 Cats
5.3.2 Fish
5.3.3 Dogs
5.3.4 Bird
5.3.5 Others
5.4 By Application Type
5.4.1 Weight Management
5.4.2 Immune system
5.4.3 Food Allergies
5.4.4 Pain Relief
5.4.5 Digestive health
5.4.6 Skin and Coat
5.4.7 Eye care
5.4.8 Others
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Diana group
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 BASF SE
8.3 Chr. Hansen A/S
8.4 Kemin Industries Inc.
8.5 Nutraceutical International LLC
8.6 Royal DSM N.V
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
